Posted by Michael Wonder on 24 Dec 2025
Thousands more people with advanced bowel cancer to benefit as NICE approves bevacizumab biosimilars
24 December 2025 - More than 7,000 people in England will now be able to access to a life-extending treatment for advanced bowel cancer.
NICE has today published final draft guidance recommending bevacizumab with chemotherapy for people with metastatic colorectal cancer.
